...
首页> 外文期刊>Robotics and Machine Learning >Advanced Bionics Announces FDA Approval for U.S. Market Re-Entry of the HiRes 90K Cochlear Implant
【24h】

Advanced Bionics Announces FDA Approval for U.S. Market Re-Entry of the HiRes 90K Cochlear Implant

机译:Advanced Bionics宣布FDA批准HiRes 90K人工耳蜗植入物在美国市场的重新进入

获取原文
获取原文并翻译 | 示例
           

摘要

Advanced Bionics (AB), the only U.S.-based manufacturer of cochlear implants and a subsidiary of nSwitzerland-based Sonova, announced the approval of the FDA for immediate market re-entry of the nHiRes 90K cochlear implant in the United States. In recent months, Advanced Bionics received approval nfrom several other regulatory agencies, including Health Canada and the European Notified Body, TUV, nto resume distribution of the HiRes 90K implant to Canada and countries accepting the CE Mark.
机译:Advanced Bionics(AB)是美国唯一的人工耳蜗制造商,也是总部位于nSwitzerland的Sonova的子公司,该公司宣布FDA批准将nHiRes 90K人工耳蜗在美国重新投入市场。在最近几个月中,Advanced Bionics获得了其他几个监管机构的批准,包括加拿大卫生部和欧洲公告机构TUV,以便继续将HiRes 90K植入物分配给加拿大和接受CE标志的国家。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号